Exercise for Childhood Cancer Survivors

(PULSE Trial)

Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: Dana-Farber Cancer Institute
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores how different levels of exercise can improve heart health in young adults who survived childhood cancer and received anthracyclines (a type of chemotherapy). The study tests two exercise programs: High-Intensity Interval Training (HIIT), which involves short bursts of intense activity, and Moderate-Intensity Continuous Training (MICT), which consists of a steady, moderate workout. This trial suits adults aged 18-39 who had cancer as a child, have been cancer-free for at least two years, and currently exercise less than an hour a week. As an unphased trial, it offers a unique opportunity to contribute to understanding how exercise can enhance heart health in cancer survivors.

Do I have to stop taking my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.

Is there any evidence suggesting that this trial's exercise programs are likely to be safe?

Research has shown that high-intensity interval training (HIIT) is generally safe and well-tolerated by cancer patients, including young survivors. Studies have found that HIIT can boost physical fitness and quality of life without causing major side effects. Early findings also suggest that HIIT is safe for childhood cancer patients without serious health problems.

Evidence also supports the safety and effectiveness of moderate-intensity continuous training (MICT). Research indicates that MICT safely improves heart health in childhood cancer survivors. Both HIIT and MICT have high adherence rates, meaning most participants can continue with the program without issues.

In summary, both HIIT and MICT are safe exercise options for childhood cancer survivors, offering positive health benefits with few reports of negative effects.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores how specific exercise regimens can benefit childhood cancer survivors, an area where traditional treatments often focus on medication and passive recovery. The trial investigates two exercise programs: High-Intensity Interval Training (HIIT) and Moderate Intensity Continuous Training (MICT). Unlike typical care, which might include recommendations for general physical activity, these programs offer structured, home-based exercises that are virtually supervised. This approach not only encourages regular physical activity but also provides tailored guidance, potentially improving survivors' overall health and quality of life. By comparing HIIT and MICT, researchers aim to find out which exercise method might be more effective in enhancing fitness and well-being in this unique population.

What evidence suggests that this trial's exercise programs could be effective for improving cardiac health in childhood cancer survivors?

This trial will compare two exercise programs for childhood cancer survivors: High-Intensity Interval Training (HIIT) and Moderate-Intensity Continuous Training (MICT). Studies have shown that HIIT can significantly enhance heart and lung fitness in cancer survivors, increasing the body's oxygen use during exercise by 10.68%, a key indicator of improved heart health. MICT also demonstrated positive results, with a 7.4% improvement in the same measure. Participants in this trial will be randomly assigned to one of these safe and effective exercise programs, both of which boost physical health in cancer survivors. While HIIT may be slightly more effective, both exercise types can improve heart health in young adults who survived cancer as children.12356

Who Is on the Research Team?

CD

Christina Dieli-Conwright

Principal Investigator

Dana-Farber Cancer Institute

Are You a Good Fit for This Trial?

This trial is for young adults aged 18-39 who survived childhood cancer, were diagnosed at age 18 or younger, finished treatment with anthracyclines at least 2 years ago, are currently in remission, do less than an hour of moderate-to-high intensity exercise per week, and have no major health issues that prevent intense exercise.

Inclusion Criteria

I have been in remission for at least 2 years since finishing cancer treatment.
Oncology survivorship provider clearance to participate in exercise
Sedentary (i.e., currently participates in ≤ 60 minutes of structured high or moderate intensity exercise/week) determined by self-report during screening using the Godin Leisure Time Exercise Questionnaire
See 7 more

Exclusion Criteria

Patients who are pregnant
Participate in more than 60 minutes of structured moderate-to-vigorous exercise per week over the last month
Patients receiving treatment for other active malignancies (except basal cell carcinoma)
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person)

Treatment

Participants engage in either high-intensity interval training (HIIT) or moderate intensity continuous training (MICT) for 16 weeks

16 weeks
3x weekly home-based virtually supervised sessions

Follow-up

Participants are monitored for changes in cardiac health and other health metrics post-intervention

4 weeks
Post-intervention visit and surveys

What Are the Treatments Tested in This Trial?

Interventions

  • HIIT Exercise Program
  • MICT Exercise Program

Trial Overview

The study compares two types of supervised exercise programs—moderate-intensity continuous training (MICT) and high-intensity interval training (HIIT)—to see which better improves heart health in young adult survivors of childhood cancer.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: High Intensity Interval Training (HIIT)Experimental Treatment1 Intervention
Group II: Moderate Intensity Continuous Training (MICT)Active Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Dana-Farber Cancer Institute

Lead Sponsor

Trials
1,128
Recruited
382,000+

Citations

Effects of high-intensity interval training on functional ... - PMC

In terms of relV̇O2PEAK, the performance of cancer patients was improved by HIIT (10.68±6.48%) and MICT (7.4±4.29%). HIIT can be favored to ...

Feasibility of High Intensity Interval Training in Survivors ...

HIIT, which alternates high-intensity effort with recovery periods, has shown benefits in adult cancer survivors but has not been tested in younger populations.

A Bout of High-Intensity Interval Training (HIIT) in Children ...

In conclusion, our preliminary data suggest that HIIT is safe and feasible in a small number of childhood cancer patients who do not suffer from ...

Effectiveness of HIIT in patients with cancer or cancer survivors

HIIT training seemed to be effective to improve cardiorespiratory fitness in cancer survivors. However, during active treatment, there were contrasting results.

High-intensity interval training (HIIT) was performed with 11 ...

High-intensity interval training (HIIT) was performed with 11 childhood cancer patients after completing a two-minute warm-up. Between each interval, there ...

Effectiveness of HIIT in patients with cancer or ...

QoL showed positive results although with some controversy. Adherence to HIIT intervention was high, ranging from 54% to 100%. Regarding adverse ...